Abstract. The genetic background of early repolarization syndrome (ERS) has not been fully understood. In this study, we identified a missense SCN5A mutation and a polymorphism in a patient with ERS and characterized the functional consequences of the two variants. The functional consequences of mutant channels were investigated with the patch-clamp technique, immunocytochemical studies and real-time PCR. A 19-year-old female proband with recurrent syncope had a documented electrocardiogram with ventricular fibrillation (VF) proceeded by large J waves in leads I, II, III, aVF and V 2 -V 6 . Genetic analysis revealed that the patient carried a missense mutation of c.4297 G>C and a synonymous polymorphism of T5457C on the same allele of the SCN5A gene. Patch-clamp experiments demonstrated that the c.4297 G>C mutation significantly reduced the sodium current (I Na ) density and altered the channel kinetics. Immunocytochemical studies demonstrated that the mutation dramatically inhibited the expression of sodium channels in the cell membrane and in the cytoplasm, although the mRNA levels remained in the normal range. Noteworthy, the reduction in I Na density may be partially restored from the co-existence of the T5457C polymorphism on the same allele by the upregulation of mRNA levels. In conclusion, our study indicated that the c.4297 G>C mutation caused the 'loss-of-function' of sodium channels that may account for the clinical phenotype of ERS. The reduction in I Na density was due to a decreased number of sodium channels caused by abnormal translation processes. The T5457C polymorphism partially rescued the I Na density of the mutant channels by the upregulation of mRNA levels.
Introduction
The early repolarization pattern consisting of a J-point elevation, notching or slurring of the terminal portion of the R wave (J wave) and tall/symmetric T wave is a common finding on the electrocardiography (ECG) in young healthy men or athletes and is considered a 'benign' ECG manifestation for a long period of time (1) (2) (3) . However, recent evidence has demonstrated that early repolarization may be associated with an increased risk for ventricular fibrillation (VF), depending on the locations and magnitude of the J wave and ST-segment elevation (4, 5) . Thus, Antzelevitch and Yan (1) proposed a new conceptual framework, inherited J wave syndromes, to describe the arrhythmic phenotypes. Inherited J wave syndromes, as a continuous spectrum of arrhythmic phenotypes, has been divided into four different subtypes in terms of anatomical locations of J wave and ST-segment elevation and clinical consequences, including early repolarization in the lateral precordial leads [early repolarization syndrome (ERS) type 1], in the inferior or inferolateral leads (ERS type 2), globally in the inferior, lateral and right precordial leads (ERS type 3) and in the right precordial leads [Brugada syndrome (BrS)] (1). However, the genetic basis of the three types of ERS has not been well defined. To date, 'loss-of-function' mutations in the CACNA1C, CACNB2 and CACNA2D1 genes and 'gain-of-function' mutations in the KCNJ8 gene have been identified in patients with ERS (6) (7) (8) .
In the present study, we described an unreported missense mutation of c.4297 G>C in the SCN5A gene, which encoded the α subunit of the cardiac voltage-gated sodium channel Nav1.5, leading to prominent J waves and ST-segment elevation in the inferior, lateral and precordial leads accompanied with VF in a female proband. We identified an unpublished synonymous single nucleotide polymorphism (SNP) of T5457C in the SCN5A gene in the proband, her mother and sister. We characterized the functional consequences of the mutation as well as the interaction between the mutation and the SNP.
A heterozygous missense SCN5A mutation associated with early repolarization syndrome Genotyping. Genomic DNA was isolated from peripheral blood leukocytes using a TIANamp Blood DNA isolation kit (Tiangen, Beijing, China) according to the manufacturer's instructions. All exons of the SCN5A, KCND3, CACNA1C, CACNB2, KCNE3, SCN1B and KCNJ8 genes were amplified by polymerase chain reaction (PCR) and were analyzed by direct sequencing. Whenever the variant was discovered in the proband or her family members, it would be confirmed in 500 unrelated healthy Chinese individuals (1,000 reference alleles) to determine the distinction between mutation and polymorphism.
Mutagenesis and expression studies. The technique for sitedirected mutagenesis and wild-type (WT)-SCN5A plasmid were prepared in our laboratory (9) . Three mutations based on the genotypes of the patient and her family (c.4297 G>C -SCN5A, T5457C-SCN5A and c.4297 G>C-T5457C-SCN5A) were created on the WT-SCN5A background (GenBank ID: NM198056). All mutations were verified by sequencing and then subcloned back into the pcDNA3.1 vector. The heterologous expression was performed as previously described (9) . Briefly, the human embryonic kidney (HEK) 293 cells were transiently transfected with 0.6 µg cDNA (detailed composition is shown in Table I ) using an Effectene Transfection Reagent (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Green fluorescent protein gene (0.2 µg) was cotransfected as an indicator. The transfected cells were cultured for 36 h before sodium current (I Na ) was recorded. More than 3 independent experiments were conducted to confirm the reproducibility of the results.
Patch-clamping. I Na was measured using whole-cell configuration of the patch-clamp technique as previously described (10) Immunocytochemistry. Immunocytochemical experiments were performed as previously described (12) . Briefly, cells were fixed, blocked and incubated with mouse monoclonal to Nav1.5 IgM primary antibody (1:40 dilution) (Abcam, Cambridge, UK) overnight at 4˚C. The cells were then incubated in anti-mouse FITC-conjugated donkey secondary antibody (1:500 dilution) (Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at room temperature in the dark. Confocal images were obtained using a confocal laser scanning microscope (Leica TCS SP2; Leica, Wetzlar, Germany) and were analyzed with NIH image software (Image J).
Statistical analysis. Data are represented as the means ± standard error of the mean (SEM). Student's t-test analysis was performed for the comparison of two means, while one-way ANOVA was performed for comparisons of multiple means using statistical software SPSS 13.0. A value of P<0.05 was considered to indicate a statistically significant difference.
Results
Clinical manifestation and genotyping. The proband, a 19-year-old female was admitted to the Fu Wai Hospital Figure 1 . Pedigree of the family. Squares and circles represent male and female members, respectively. Solid circle (arrow) represents the proband carrying a heterozygous G4297C mutation and a heterozygous T5457C polymorphism in the SCN5A gene. The individual I-2 is asymptomatic despite carrying the G4297C mutation. Moreover, she also has a homozygous T5457C polymorphism.
(Beijing, China) due to a history of recurrent syncope at rest (a total of 4 times since the age of 16). The ECG that was obtained at the emergency department exhibited prominent J waves and ST-segment elevation in leads I, II, III, aVF and V 2 -V 6 ( Fig. 2B ) before VF occurred (Fig. 2C) . Subsequently, the VF episode was terminated by cardioversion. There was no difference in clinical state that may explain the marked J waves and ST-segment elevation in the documented ECG. Myocardial infarction was excluded by cardiac enzyme tests and coronary angiography. The routine echocardiography demonstrated a structural and functional normal heart. The baseline ECG was within normal limits with the exception of tiny, hump-like J waves in the inferior leads and a borderline prolongation of the PR interval (200 msec) ( Fig. 2A) . The amplitude of ST-segment elevation fluctuated from day to day. Programmed electrical stimulation induced VF that was converted to sinus rhythm by cardioversion. Since the sodium channel blockers, such as ajmaline, flecainide and procainamide, were not available in China, drug challenge was not performed. According to the clinical manifestations, ERS type 3 was diagnosed and an implantable cardioverter defibrillator was implanted with the pacing rate programmed to 60 bpm. After amiodarone (200 mg/day) and metoprolol (50 mg/day) administration, the proband remained symptomfree for a period of 18 months. However, in the nineteenth month, the patient was shocked due to a VF episode with a heart rate >260 bpm. All family members lived asymptomatic and there was no family history of sudden death.
A heterozygous missense mutation of c.4297 G>C, located in exon 24 of the SCN5A gene, was identified in the proband using direct DNA sequencing (Fig. 3A) . The mutation led to a substitution of an arginine for a glycine at position 1433 that was predicted to be in the extracellular loop between the pore region and the S6 transmembrane segment in the domain III of the α subunit of the sodium channels (Fig. 3C) . The c.4297 G>C mutation was also detected in her mother but not in 500 unrelated healthy subjects. In addition, a heterozygous SNP, T5457C, which is located in exon 28 of the SCN5A gene, was discovered in the proband; however, the T5457C polymorphism did not cause a change in the protein sequence ( Fig. 3B and C) . Genetic analysis revealed that her mother carried a homozygous T5457C polymorphism and her sister carried a heterozygous T5457C polymorphism, while her farther carried no such variants (Fig. 1) . Since the substitution of C for T occurred at a frequency of 42.67% within a population including 500 unrelated healthy subjects, we confirmed that the T5457C variant was a polymorphism. Moreover, no other mutations or variants were discovered in the screened genes in the proband and the family.
Electrophysiology of G4297C and T5457C channels. I Na was recorded from the HEK293 cells transiently transfected with the WT-SCN5A, G4297C-SCN5A or T5457C-SCN5A plasmid using the whole-cell configuration of the patch-clamp technique. The G4297C mutation dramatically reduced I Na density (-107.65±14.70 pA/pF in WT, n=8 vs. -15.75±3.72 pA/pF in the mutant, n=12, P<0.05) (Fig. 4A and C) and shifted the steady-state activation curve to a more positive potential compared with the WT channels (P<0.05) (Fig. 5C and Table I ). By contrast, the mutation had no effect on the steady-state inactivation (Fig. 5D and Table I ), although it inhibited the recovery from inactivation (P<0.05) (Fig. 5B and Table I ).
The T5457C variant was a relative benign polymorphism since it did not change the current density (-115.47±23.25 pA/pF, n=8, P>0.05) (Fig. 4B) , steady-state activation and steady-state inactivation of the sodium channels, although it prolonged the recovery from inactivation compared with the WT channels (P<0.05) ( Table I) .
Rescue effect of the T5457C polymorphism on G4297C mutant channels. Furthermore, we characterized the interaction between the G4297C mutation and the T5457C polymorphism. Inserting the T5457C polymorphism into the G4297C Figure 5 . Peak I Na densities and channel kinetics. (A) The I Na densities of WT, T5457C SNP and WT + T5457C SNP were similar (P>0.05). The T5457C SNP slightly increased the current density, while the G4297C mutation significantly reduced I Na to 14.63% of the WT current (P<0.05). The I Na densities of the cells transfected with G4297C-T5457C-SCN5A or cotransfected with G4297C and T5457C or WT-SCN5A were all significantly increased compared to that of cells transfected with the G4297C mutant alone (P<0.05). In the heterozygous expression system, the coexpression of G4297C-T5457C-SCN5A with WT-SCN5A (as the nature of the proband) or with T5457C-SCN5A (as the nature of her mother) increased the I Na up to 65 or 70% compared to the WT channels. (B) Recovery from inactivation was slower in the G4297C mutant compared to that in the WT channels. (C) The G4297C mutation shifted the steady-state activation curve to a more positive potential, while (D) it had no effect on the steady-state inactivation. * Significant difference from the WT control, P<0.05. mutant construct (G4297C-T5457C-SCN5A) partially restored the I Na density (-44.12±10.45 pA/pF, n=8) (P<0.05, Fig. 4D ) but without having an effect on mutant channel kinetics compared with the G4297C channels (Table I) . However, coexpression of the T5457C polymorphism and G4297C mutation on separate constructs had no significant effect on the I Na density of mutant channels, since the similar current densities were recorded from cells coexpressing G4297C-SCN5A and WT or T5457C-SCN5A (-55.66±18.01 pA/pF, n=7 vs. -61.02±17.80 pA/pF, n=5, P>0.05) (Fig. 4E and F) . Additionally, we expressed the cDNA constructs to simulate the distribution patterns of G4297C and T5457C in the proband and her family. Coexpression of G4297C-T5457C-SCN5A with WT-SCN5A (as the nature of the proband) or G4297C-T5457C-SCN5A with T5457C-SCN5A (as the nature of her mother) increased the I Na up to 65 or 70% in the WT channels. The peak current densities are plotted in Fig. 5A for all combinations of WT-SCN5A, G4297C-SCN5A, T5457C-SCN5A and G4297C-T5457C-SCN5A constructs. (E) Summary data demonstrated that the membrane to intracellular fluorescence ratio in the G4297C group was markedly reduced compared to that in the WT group; however, the ratio significantly increased in the G4297C-T5457C group compared with the G4297C group. * P<0.05 represents a significant difference from the WT control, # P<0.05 represents a significant difference from the G4297C group; n=10 in each group. Table I . Average values of activation, inactivation and recovery from inactivation parameters. --------------------------------------------------------------------------------------- Transcription of WT and mutant cDNAs. Quantitative real-time PCR was used to detect the WT and mutant mRNA levels. The mRNA of SCN5A was not detected in the non-transfected cells.
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There was no significant difference in mRNA levels between cells transfected with WT-SCN5A and the G4297C mutant (P>0.05). The mRNA level of G4297C-T5457C-SCN5A was increased by 6-fold compared to that of WT-SCN5A (P<0.05).
Confocal imaging.
To investigate the cellular localization of the WT and mutant channels, immunocytochemical experiments were performed. The non-transfected cells displayed background fluorescence (Fig. 6A) . As expected, the periphery localization was exhibited in cells with WT channels (Fig. 6B) . By contrast, cells transfected with G4297C mutant channels displayed a very low expression both in the cell membrane and in the cytoplasm (Fig. 6C) . However, the G4297C-T5457C channels demonstrated a significantly higher expression with a peripheral localization pattern compared to that of the G4297C channels, consistent with the increased mRNA levels of G4297C-T5457C-SCN5A compared with the G4297C channels, which indicated that the T5457C polymorphism partially rescued the expression of G4297C mutant channels (Fig. 6D ). Summary data depicted in Fig. 6E revealed that the average fluorescence intensity per unit area in the membrane divided by the average fluorescence intensity per unit area in intracellular compartments (membrane to intracellular fluorescence ratio) was markedly reduced in the G4297C group compared to that in the WT group (P=0.0007); however, the ratio significantly increased in the G4297C-T5457C group compared with the G4297C group (P=0.017) (n=10 for all groups).
Discussion
In this study, we identified an unreported SCN5A mutation G4297C in a young female patient with idiopathic VF followed by J waves and ST-segment elevation in the inferior, lateral and precordial leads demonstrated by documented ECG. According to the clinical manifestation of the lack of typical Brugada waves in the right precordial V 1 lead, the patient was not diagnosed as BrS (13, 14) . Recently, a multicenter study revealed that J wave and ST-segment elevation in the inferior or lateral leads, also termed as early repolarization (15, 16) , accounted for 31% of 206 patients with idiopathic VF (4). It has also been reported that up to 11% of patients with BrS presented J wave and ST-segment elevation in the inferior-lateral leads associated with an increased number of symptoms (5) . Therefore, the nomenclature of ERS or BrS remains unclear. Based on the new conceptual framework proposed by Antzelevitch and Yan (1), our patient may be diagnosed as ERS type 3.
In the present study, we reported a missense G4297C mutation in the SCN5A gene. After excluding variants in other genes associated with ERS (6) (7) (8) and BrS (17) , including KCND3, CACNA1C, CACNB2, KCNE3, SCN1B and KCNJ8, we speculated that the G4297C mutation in the SCN5A gene was the causative mutation. The patch-clamp study demonstrated that the G4297C mutation caused a significant decrease in I Na density as well as altered biophysical characteristics of sodium channels such as prolonged recovery time from inactivation and depolarizing shift in activation.
The altered properties predisposed the sodium channels to a 'loss-of-function'. Further study demonstrated that the mRNA levels of WT and G4297C mutant channels were similar. However, immunocytochemistry demonstrated that the G4297C mutant channels displayed a very low expression both in the cell membrane and in the cytoplasm. The result suggests that G4297C does not cause a trafficking defect (18) , in contrast, it affects the translation process or degradation of the mutant protein. This mechanism differs from three wellknown primary mechanisms that cause a 'loss-of-function' of sodium channels such as i) formation of nonfunctional channels; ii) altered gating properties; and iii) defective trafficking (18, 19) . Thus, our findings may represent a novel mechanism for the 'loss-of-function' of sodium channels.
Moreover, several studies found that the R282H mutation in the SCN5A gene, which leads to BrS, may be fully rescued by the H558R polymorphism that restores the trafficking of the mutant protein (20, 21) . The rescue effect of the synonymous polymorphism T5457C identified in our study has not yet been investigated. Our study demonstrated that T5457C did partially restore the G4297C mutant channels based on the fact that the mRNA level of the G4297C-T5457C-SCN5A mutant significantly increased compared to that of the G4297C mutant, corresponding to a concomitant proportional increase in the number of sodium channels on the cell surface. A similar phenomenon has been observed in the ABCC2 gene that encodes the multidrug resistanceassociated protein 2 (MRP2). The synonymous C1146G SNP in the ABCC2 gene increased MRP2 mRNA expression by 2-fold in human livers (22) . However, the essential mechanism by which a synonymous SNP increases mRNA expression remains unclear. Several studies have focused on the possibility that the synonymous SNP alters the stability of mRNA, a phenomenon suggested by the synonymous C3435T SNP in the ABCB1 gene, encoding multidrug resistance polypeptide 1 and the synonymous C971T SNP in the CDSN gene encoding corneodesmosin (23, 24) . Another explanation was that the SNP may be in linkage disequilibrium with other polymorphism(s) acting at the transcriptional level (22) .
At present, the transmural voltage gradient mediated by the transient outward current (I to ) during the early repolarization phase has been accepted as an explanation of the pathophysiological mechanism of J wave or ST-segment elevation on the ECG when the corresponding inward I Na was reduced (25) . I to was often more prominent in the epicardium of the right ventricle compared to that of the left ventricle (26) , and therefore, ST-segment elevation was predisposed to localizing in the right precordial leads, as noted in BrS. By contrast, in our study, the J waves and ST-segment elevation of the proband were confined to the inferior, lateral and left precordial leads. The possible explanation may be associated with the gender-related difference in I to distribution. In the human ventricle, the transmural I to gradient is formed by the differential expression of KChIP2, the gene encoding the β subunit of the I to (27) . The expression of KChIP2 gene is negatively regulated via the homeodomain Iroquois transcription factor IRX5 and IRX3 (28) . Recently, Gaborit et al (28) provided evidence that the expression of KChIP2 is increased in the female left ventricle, consistent with the decreased expression of IRX3 and IRX5 compared with the right ventricle. The distinction of expression levels of KChIP2, IRX3 and IRX5 between male and female hearts may cause the J waves and ST-segment elevation in the inferior, lateral and left precordial leads in female patients as noted in our proband.
We reported a missense mutation of G4297C in the SCN5A gene, which caused the 'loss-of-function' of sodium channels, leading to the clinical phenotype of ERS type 3. Our findings may represent a novel mechanism for the 'loss-of-function' of sodium channels by decreasing the number of sodium channels due to abnormal translation processes. The synonymous T5457C polymorphism may partially restore the function of the G4297C mutant channels through the upregulation of mRNA levels. However, several limitations existed in this study. First, the reasons for incomplete penetrance in patient I-2 depicted in Fig. 1 were not elucidated. Second, although the probability was very low, it was unclear whether the reported mutation and the SNP were on the same allele. The reason why the T5457C SNP prolonged the recovery from the inactivation of the sodium channels requires further investigation.
